Skip to main content

Table 3 Comparison of the distribution of individual components of metabolic syndrome (according to AHA/NHLBI definition) between RA patients and controls

From: Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity

  Early RA patients ( n= 160) Controls ( n= 160) P value
Patients who met AHA/NHLBI MetS definition 28 (17.5) 48 (30) 0.01
Patients within each category of MetS definition with a particular individual component    
 BMI component 18 (64.3) 42 (87.5) 0.02
 TG component 26 (92.9) 43 (89.6) 1
 C-HDL component 27 (96.4) 46 (95.8) 1
 Blood pressure component 10 (35.7) 11 (22.9) 0.29
 Fasting glucose component 15 (53.6) 16 (33.3) 0.10
  1. Data presented as n (%). AHA/NHLBI, The American Heart Association/National Heart, Lung and Blood Institute; BMI, body mass index; C-HDL, high-density lipoprotein-cholesterol; MetS, metabolic syndrome; RA, rheumatoid arthritis; TG, triglycerides.